CCMA: Pharmacology Basics

The DEA strictly regulates the disposal of controlled substances to prevent diversion. Expired Schedule II medications must be destroyed beyond reclamation, requiring two authorized witnesses and the completion of DEA Form 41. Option D correctly identifies this legal protocol. Option A is incorrect because flushing medications violates environmental guidelines and DEA rules. Option B is incorrect because sharps containers are for needles, and placing intact patches there risks diversion. Option C is incorrect because clinics cannot arbitrarily transfer controlled substances without proper reverse distributor documentation.

When handling requests for sensitive treatments like a controlled substance, the medical assistant must confirm the caller's identity, even if the caller ID matches and the patient is in a rushed, noisy environment. Option C is correct because HIPAA protocols require verifying at least two demographic identifiers (such as name and date of birth) before accessing or discussing protected health information. Option A is incorrect because rushing the process compromises security and violates identity verification standards. Option B is incorrect because the assistant can quickly verify identity rather than dismissing the patient's immediate need. Option D is incorrect because routing the prescription without first confirming the caller's identity risks sending medication based on a fraudulent request, which is a severe compliance violation.

DEA regulations and best practices require that wasting of controlled substances be performed with a witness and accurately recorded in the controlled substance log. Option C fulfills both requirements by involving a licensed colleague as witness and documenting the waste. Option A omits the witness and proper log entry, which is noncompliant. Option B uses an inappropriate witness—the patient—who does not provide independent verification as required for controlled substance accountability. Option D is unnecessary because partial waste from a single-dose vial in an office setting is typically rendered unusable on-site with documentation, not returned to the pharmacy. The medical assistant must ensure that the controlled substance waste is witnessed and logged correctly.

The correct answer is A because Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit prostaglandins, which are necessary to protect the gastric mucosal lining. Giving an NSAID to a patient with a history of peptic ulcer disease significantly increases their risk of severe gastrointestinal bleeding. Option B is incorrect because acetaminophen is generally safe for the stomach, though it lacks anti-inflammatory properties. Option C is incorrect as opioids are prescription-only, not over-the-counter, and do not primarily cause ulcers. Option D is incorrect because topical corticosteroids act locally and do not typically cause systemic gastrointestinal bleeding, making them a safer alternative if prescribed, though they are not the high-risk oral classification in question.

Nonselective beta blockers like propranolol are often used for migraines and tachycardia but can cause bronchoconstriction. This makes them strictly contraindicated for patients with a history of bronchial asthma. Calcium channel blockers manage heart rate but do not affect airway reactivity, making them safer for asthmatics. Angiotensin receptor blockers treat hypertension without causing bronchospasms. Serotonin receptor agonists are indicated for migraines and do not impact respiratory function. Recognizing this contraindication prevents life-threatening asthma exacerbations.